title: The role and extension of lymphadenectomy in bladder cancer: a review of the current literature.
abstract: Radical cystectomy (RC) with pelvic lymph node dissection (LND) is the gold standard for high grade and muscle invasive bladder cancer. Although consensus exists on the need for node dissection, its extent and role are still matter of debate. However, an ever-growing body of data supports an extended dissection since it may provide a survival advantage in both node positive and node negative patients without significantly increasing morbidity and mortality. Besides dissection extent, the modality of specimen submission and node retrieval have a key role in the quality of node assessment. Moreover the stage of primary bladder tumor, the total number of lymph nodes removed, the lymph node tumor burden, the extracapsular extension and the lymph node density have been demonstrated to be important prognostic variables in patients undergoing cystectomy with node metastases and could be useful to accurately stratify patient risk in order to identify those who may benefit from adjuvant therapies. Even if evidence from the literature is only based on retrospective studies, an extended dissection at the time of cystectomy appears to provide a more accurate staging and enhance survival; future prospective studies taking into account the new prognostic factors are needed.
authors.affiliation: Department of Urology, Ospedale Santa Chiara, University of Pisa, Italy. mogorovich@hotmail.it
authors.forename: Andrea
authors.initials: A
authors.lastname: Mogorovich
authors.forename: Gianluca
authors.initials: G
authors.lastname: Giannarini
authors.forename: Francesca
authors.initials: F
authors.lastname: Manassero
authors.forename: Maurizio
authors.initials: M
authors.lastname: De Maria
authors.forename: Girolamo
authors.initials: G
authors.lastname: Fiorini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Di Paola
authors.forename: Cesare
authors.initials: C
authors.lastname: Selli
mesh_terms: D015653:Cystectomy / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000601:surgery*